We found that MI efficiently inhibits bladder cancer progression both in vitro and in vivo by deactivating the Nox 4/NF-κB/HIF-1α signaling pathway via upregulating miR-26b expression. Here, NFKB1 is linked to urinary bladder carcinoma.